Evidence map›Paper›PMID 21185416›Full record

ArticleBone2011

Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone.

Jeffry S Nyman, Jesse L Even, Chan-Hee Jo, Erik G Herbert, Matthew R Murry, Gael E Cockrell, Elizabeth C Wahl, R Clay Bunn, Charles K Lumpkin, John L Fowlkes and 1 more

Abstract read
In one paragraph

Article in Bone, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. An engineered dual function peptide to repair fractured bones.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  10. Identifying Bone Matrix Impairments in a Mouse Model of Neurofibromatosis Type 1 (NF1) by Clinically Translatable Techniques.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Jeffry S NymanDepartment of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN 27212, USA. jeffry.s.nyman@vanderbilt.edu
Jesse L Even
Chan-Hee Jo
Erik G Herbert
Matthew R Murry
Gael E Cockrell
Elizabeth C Wahl
R Clay Bunn
Charles K Lumpkin
John L Fowlkes
Kathryn M Thrailkill
Arkansas Children's Hospital · USVanderbilt University Medical Center · USUniversity of Arkansas for Medical Sciences · USBaylor Scott & White Health · USKnoxville College · US

Funding

ETHANOL AND OSTEOBLASTOGENESIS: ROLES OF IL-1 AND TNFR01AA012223 · NIAAA · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI LUMPKIN, CHARLES K · 1999 to 2009
$2.2M
THE PHYSIOLOGY OF IGFBP DEGRADING PROTEINASES IN BONER01DK055653 · NIDDK · UNIVERSITY OF KENTUCKY · PI FOWLKES, JOHN L · 1999 to 2009
$2.0M
EXTRAMURAL RES FACILITIES CONSTR PROJC06RR016517 · NCRR · ARKANSAS CHILDREN'S HOSP (LITTLE ROCK) · PI BURKS, ARVIL WESLEY · 2001 to 2002
$1.3M
The Insulin/IGF-I Axis in Diabetic OsteopathyR01DK084045 · NIDDK · UNIVERSITY OF KENTUCKY · PI FOWLKES, JOHN L · 2012 to 2015
$1.3M
NCRR NIH HHS C06 RR016517NCRR NIH HHS C06RR16517NIAAA NIH HHS R01 AA012223NIAAA NIH HHS R01AA012223NIDDK NIH HHS R01 DK055653NIDDK NIH HHS R01DK055653NIDDK NIH HHS R01 DK084045
6 · The paper itself

Abstract

Type 1 diabetes (T1DM) increases the likelihood of a fracture. Despite serious complications in the healing of fractures among those with diabetes, the underlying causes are not delineated for the effect of diabetes on the fracture resistance of bone. Therefore, in a mouse model of T1DM, we have investigated the possibility that a prolonged state of diabetes perturbs the relationship between bone strength and structure (i.e., affects tissue properties). At 10, 15, and 18 weeks following injection of streptozotocin to induce diabetes, diabetic male mice and age-matched controls were examined for measures of skeletal integrity. We assessed 1) the moment of inertia (I(MIN)) of the cortical bone within diaphysis, trabecular bone architecture of the metaphysis, and mineralization density of the tissue (TMD) for each compartment of the femur by micro-computed tomography and 2) biomechanical properties by three-point bending test (femur) and nanoindentation (tibia). In the metaphysis, a significant decrease in trabecular bone volume fraction and trabecular TMD was apparent after 10 weeks of diabetes. For cortical bone, type 1 diabetes was associated with decreased cortical TMD, I(MIN), rigidity, and peak moment as well as a lack of normal age-related increases in the biomechanical properties. However, there were only modest differences in material properties between diabetic and normal mice at both whole bone and tissue-levels. As the duration of diabetes increased, bone toughness decreased relative to control. If the sole effect of diabetes on bone strength was due to a reduction in bone size, then I(MIN) would be the only significant variable explaining the variance in the maximum moment. However, general linear modeling found that the relationship between peak moment and I(MIN) depended on whether the bone was from a diabetic mouse and the duration of diabetes. Thus, these findings suggest that the elevated fracture risk among diabetics is impacted by complex changes in tissue properties that ultimately reduce the fracture resistance of bone.

Indexed as

AnimalsBone and BonesBone DensityDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1MaleMiceMice, Inbred DBAStreptozocinTomography, X-Ray ComputedStreptozocin

Identifiers

PMID21185416
PMCPMC3062641
OpenAlexW2148998300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.